Proof-of-concept, exploratory human study of PT-101
Phase of Trial: Phase I
Latest Information Update: 18 Mar 2019
Price : $35 *
At a glance
- Drugs Tamoxifen (Primary) ; Tamoxifen
- Indications Atrophic vaginitis
- Focus Proof of concept; Therapeutic Use
- Sponsors Dare Bioscience
- 18 Mar 2019 According to the Dare Bioscience media release, data from this trial were published in Clinical and Experimental Obstetrics and Gynecology.
- 18 Mar 2019 Results presented in the Dare Bioscience media release.
- 14 May 2018 New trial record